Navigating GLP-1 Compliance for Med Spas with Lengea Law
The regulatory landscape is shifting, and it’s shifting fast.
That’s exactly why we joined forces with Shirin Adelman from Lengea Law to host Peptides Legal Update 2026: Compliance, Crackdowns, and Medical Director Risk—a candid conversation about the legal realities that are already impacting practices across the country—and what they could mean for your business next
Shirin Adelman, Esq. is a Partner at Lengea Law with deep expertise in healthcare and regulatory compliance…and a familiar face over here at Injectables EDU, having spoken at our 2025 Summit and returning as a Summit speaker in 2026.
If you’ve been feeling confused, concerned, or overwhelmed by all the chatter around regulations, this is your chance to get clear, compliant, and confident…directly from the legal experts.
Key Takeaways From Peptides Legal Update 2026: Compliance, Crackdowns, and Medical Director Risk
1. Compliance Requirements Are Expanding Across States
New legislation (like the recent bill in Indiana) signals increasing oversight of med spa operations, particularly around GLP-1 medications and peptides. Clinics may soon be required to register with pharmacy boards, track adverse events, and maintain more detailed documentation and sourcing records. Even if these rules haven’t reached your state yet, they indicate where regulation is heading.
2. Proper Patient Onboarding Is One of the Biggest Compliance Factors
One of the most important steps for GLP-1 compliance for med spas is ensuring proper patient onboarding. This includes conducting a documented good-faith exam, creating patient-specific orders, and maintaining clear records in the EMR. When audits occur, regulators often look first at whether clinics followed the correct medical process before providing treatment.
3. Structure and Ownership of Your Clinic Matters
Many states enforce rules around the corporate practice of medicine, meaning non-physicians may need to operate through a management company rather than directly owning the medical clinic. If your business structure isn’t compliant, it can quickly become a major issue during audits or investigations.
4. Absentee Medical Directors Create Real Risk
While some states technically allow remote or multi-state medical directors, regulators increasingly expect them to be actively involved in clinic operations. During investigations, medical directors may be questioned in detail about clinic procedures, patient care protocols, and medication handling. If they are unfamiliar with day-to-day operations, it can raise red flags.
5. Being Proactive About Compliance Can Prevent Major Headaches
The biggest theme from the discussion: don’t wait for an audit to get compliant. Clinics that proactively implement strong documentation, appropriate supervision, and clear protocols are far more likely to navigate audits successfully and avoid costly disruptions
So, What’s Next?
Regulations around GLP-1 medications, peptides, and med spa operations are evolving quickly, and staying ahead of compliance is essential for protecting your business. So if you’re wondering what your next step should be, we’ve got you covered:
- Ask your questions: Book a free 20-minute mentoring call to talk through challenges, goals, or next moves with the Co-Founders of Injectables EDU.
- Go deeper in person: Join us at the Injectables EDU Summit to dive deeper into compliance, business growth, and clinical excellence with experts from Lengea Law and Injectables EDU for more expert insights and opportunities to meet 1:1 with Shirin to get personalized guidance for your practice.
If this webinar raised questions about your clinic’s compliance strategy, the Summit is the perfect place to get answers—and ensure your business is set up for long-term success.
